Showing results (181-190 of 470) with videos related to
Sort By:
Pageof 47
European Journal of Neurology|May 14, 2008
The functional MAOA-uVNTR promoter polymorphism in patients with frontotemporal dementiaA Reif, E Scarpini, E Venturelli, et al.Neurochemistry International|February 17, 2000
Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF)R Mössner, S Daniel, D Albert, et al.Neuroscience|March 8, 2005
The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the ratE Asan, D M Yilmazer-Hanke, M Eliava, et al.Life Sciences|January 1, 1990
Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depressionK P Lesch, S Mayer, J Disselkamp-Tietze, et al.Psychiatria Clinica|January 1, 1983
Dexamethasone suppression test combined with total sleep deprivation in depressed patientsS Kasper, H W Moises, H BeckmannNeuropsychobiology|January 1, 1982
Analgesic and euphoric effects of high dose diazepam in schizophreniaS Haas, H M Emrich, H BeckmannMedizinische Klinik|November 23, 1979
[Meproscillarin in patients with renal failure and concomitant heart failure (author's transl)]H Beckmann, G G Belz, E QuellhorstPsychoneuroendocrinology|January 1, 1985
Increased CSF cortisol levels after neuroleptic treatment in schizophreniaW F Gattaz, D Hannak, H BeckmannArchiv Fur Psychiatrie Und Nervenkrankheiten|January 1, 1982
Glutamate in schizophrenics and healthy controlsW F Gattaz, D Gattaz, H BeckmannBiological Psychiatry|August 1, 1984
Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patientsW F Gattaz, H Cramer, H BeckmannPageof 47